Medicine and Dentistry
Neoadjuvant Chemotherapy
100%
Xenotropic MuLV Related Virus
98%
Angiosarcoma
98%
Carcinosarcoma
98%
Patient
65%
Muscle Invasive Bladder Cancer
62%
Predictor
54%
Infection
49%
Cancer Specific Survival
47%
Overall Survival
42%
Transitional Cell Carcinoma
42%
Upper Urinary Tract
42%
Progression Free Survival
34%
Neoplasm
33%
Virus Infection
29%
Tonsil
29%
Element
28%
Serositis
24%
Comprehension
23%
Multivariate Analysis
21%
Cystectomy
21%
Retroviridae
19%
Virus Infectivity
19%
Tissues
19%
Cell Line
19%
Ex Vivo
19%
Lymphoid Organ
19%
Laboratory
19%
Kaplan Meier Method
18%
Decision Making
16%
Clinical Stage
16%
Squamous Cell
14%
Specimen
14%
Autopsy
14%
Sarcomatoid
14%
Chondrosarcoma
14%
Sputum
14%
Respiratory Failure
14%
Liposarcoma
14%
Leiomyosarcoma
14%
Nephroureterectomy
14%
Diaphragm
14%
Microhematuria
14%
Dyspnea
14%
Lung Nodule
14%
Malignant Fibrous Histiocytoma
14%
Exploratory Behavior
14%
Nephrectomy
14%
Low Back Pain
14%
Metastatic Carcinoma
14%
Nursing and Health Professions
Neoadjuvant Chemotherapy
100%
Neutrophil Lymphocyte Ratio
98%
Carcinosarcoma
98%
Angiosarcoma
98%
Patient
98%
Muscle Invasive Bladder Cancer
62%
Cancer Specific Survival
47%
Inpatient
42%
Overall Survival
42%
Progression Free Survival
34%
Inflammation
24%
Procedures
21%
Cystectomy
21%
Multivariate Analysis
21%
Kaplan Meier Method
18%
Malignant Fibrous Histiocytoma
14%
Chondrosarcoma
14%
Osteosarcoma
14%
Liposarcoma
14%
Fibrosarcoma
14%
Proportional Hazards Model
13%
Follow up
13%
Combination Therapy
13%
Bladder Cancer
9%
Survival
9%
Perioperative
9%
Algorithm
8%
Regression Analysis
8%
Survival Rate
8%
Univariate Analysis
8%
Tertiary Care Center
8%
Biological Marker
8%
Log Rank Test
8%
Clinical Practice
8%
Immunology and Microbiology
Xenotropic MuLV Related Virus
98%
Neutrophil Granulocyte
98%
Lymphocyte
93%
Tonsil
29%
Viral Disease
29%
Tissues
29%
Inflammation
24%
Retrovirus
19%
Cells
19%
Lymphoid Tissue
19%
Virus Infectivity
19%
Electric Potential
19%
Supernatant
19%
Cancer Specific Survival
14%
Bladder
14%
Squamous Cell
14%
Survival
9%
Prostate Cancer Cell Line
9%
Murine Leukemia Virus
9%
Progression Free Survival
9%
Association
9%
Comprehension
9%
Overall Survival
9%
B Cell
9%
Kinetics
9%
Biological Product
9%
Immunity
9%
Human Cell
9%
Viral Replication
9%